Evidence map›Paper›PMID 38131915›Full record

ArticleGels (Basel, Switzerland)2023

Development and Characterization of Econazole Topical Gel.

Mohammad F Bayan, Balakumar Chandrasekaran, Mohammad H Alyami

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Investigating topical delivery of erythromycin laden into lipid nanocarrier for enhancing the anti-bacterial activity.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Mohammad F BayanFaculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.ORCID 0000-0002-1736-1799
Balakumar ChandrasekaranFaculty of Pharmacy, Philadelphia University, P.O. Box 1, Amman 19392, Jordan.ORCID 0000-0003-4198-8679
Mohammad H AlyamiDepartment of Pharmaceutics, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia.ORCID 0000-0003-2731-1071
Philadelphia University · JONajran University · SA

Funding

Deanship of Scientific Research at Najran University NU/RG/MRC/12/20Philadelphia University, Amman, Jordan 511/34/100 PU
6 · The paper itself

Abstract

The purpose of this work was to develop a novel topical formulation of econazole nitrate based on gel that can be easily scaled up in one pot for the potential treatment of fungal and yeast infections. Econazole nitrate, a topical antifungal, is used to treat tinea versicolor, tinea pedis, and tinea cruris. Compared to applying cream or ointment, topical gels offer numerous advantages, one of which is that the drug is released more quickly to the intended site of action. A viscous mixture of propylene glycol, Capmul

Indexed as

Carbopol® 940cutaneous candidiasiseconazolesustainabilitytopical gel

Identifiers

PMID38131915
PMCPMC10743284
OpenAlexW4389049770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.